FM
CSLT

Fondren Management’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Fondren Management’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-300,000
Closed -$249K – 25
2020
Q2 		$249K Buy
+300,000
New +$223K 0.96% 21

Other funds holding CSLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fondren Management's CSLT Position: Q3 2020 in Review

Fondren Management sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q3 2020, closing a stake of 300,000 shares — an estimated $249K sold.

Fondren Management first reported a position in CSLT in Q2 2020 and held it in 1 quarter. The position peaked at $249K in Q2 2020. 81 funds tracked by Wall St. Rank hold CSLT as of Q3 2020.

  • Fondren Management reported no remaining CASTLIGHT HEALTH, INC. position as of Q3 2020 after selling out during the quarter.
  • Fondren Management sold 300,000 CASTLIGHT HEALTH, INC. shares in Q3 2020, an estimated $249K.
  • Fondren Management first reported a position in CASTLIGHT HEALTH, INC. in Q2 2020 and held it in 1 quarter.
  • Fondren Management's CASTLIGHT HEALTH, INC. position peaked at $249K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q3 2020.

Based on Fondren Management's 13F filing for Q3 2020, filed 13 Nov 2020.